Secondly, there was controversy over the expression levels of lncRNA ANRIL and lncRNA MIAT in ischemic stroke patients across different studies, necessitating more clinical and cellular experiments to clarify their roles. Here, CDKN2B-AS1 is linked to ischemic stroke.